Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kent A Hanson"'
Autor:
Victoria Kulbokas, Kent A Hanson, Mary H Smart, Monika Rao Mandava, Todd A Lee, A Simon Pickard
Publikováno v:
Drugs in Context, Vol 10, Pp 1-20 (2021)
Background: Academic detailing (AD) is a tailored, interactive educational outreach intervention that may improve patient outcomes. Insight into the design of AD interventions and the extent to which they are effective can help inform future AD-based
Externí odkaz:
https://doaj.org/article/5d22dbf1153047748c52eeebabfa62c6
Autor:
Peter Anderson, James Piercy, Jenny Austin, Simran Marwaha, Kent A. Hanson, Ernest H. Law, Gregor Schaefer, Samantha K. Kurosky, Sergio Vañó-Galván
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 12, Pp 3243-3258 (2024)
Abstract Introduction Alopecia areata (AA) is an autoimmune disease that causes scalp, face, and/or body hair loss. Recently, oral treatments with kinases inhibition became the first approved therapies for severe AA. An understanding of the use and e
Externí odkaz:
https://doaj.org/article/7c035ecac96441ae8a0a90fdc35e3ebd
Autor:
Peter Anderson, James Piercy, Jenny Austin, Simran Marwaha, Kent A. Hanson, Ernest H. Law, Gregor Schaefer, Samantha K. Kurosky, Sergio Vañó-Galván
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 12, Pp 3259-3259 (2024)
Externí odkaz:
https://doaj.org/article/c1c49305564a4fb2b3d0ea4f43d88171
Publikováno v:
Targeted Oncology. 18:327-358
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db9ce6847d3835c7cd0b909e02289f67
https://doi.org/10.1007/s11523-023-00957-7
https://doi.org/10.1007/s11523-023-00957-7
Autor:
Katie Mycock, Kent A. Hanson, Gavin Taylor-Stokes, Gary Milligan, Christian Atkinson, Debanjali Mitra, Salena Preciado, Ernest H. Law
Publikováno v:
Clinical Therapeutics. 44:1588-1601
Palbociclib was the first cyclin-dependent kinase 4/6 inhibitor approved by the US Food and Drug Administration for use in combination with aromatase inhibitors (AIs) as initial endocrine-based therapy or with fulvestrant in postmenopausal women who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66560b67707ab61bd5468b11b892edbd
https://doi.org/10.1016/j.clinthera.2022.11.004
https://doi.org/10.1016/j.clinthera.2022.11.004
Autor:
Kent A. Hanson, Mary H. Smart, Monika Rao Mandava, Emir Carkovic, Mezhgan Aslamy, Todd A. Lee, A. Simon Pickard
Publikováno v:
Journal of the American Pharmacists Association. 63:608-613.e3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86e0ba923fb9f9430d6b8e8446ba7201
https://doi.org/10.1016/j.japh.2022.12.018
https://doi.org/10.1016/j.japh.2022.12.018
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:PO-097
Background: The CPS+EG system, based on pretreatment clinical and post-treatment pathologic stage (CPS), estrogen receptor status (E), and tumor grade (G), has been used to refine estimations of prognosis in patients with hormone receptor-positive (H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a5e1fe42e8ed68a35fa9285460791a8
https://doi.org/10.1158/1538-7755.disp21-po-097
https://doi.org/10.1158/1538-7755.disp21-po-097